Paloma Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,746
| Closed | -$623K | – | 469 |
|
|
2024
Q3 | $623K | Buy |
+7,746
| New | +$623K | 0.02% | 326 |
|
|
2022
Q1 | – | Sell |
-6,000
| Closed | -$318K | – | 1487 |
|
|
2021
Q4 | $318K | Buy |
+6,000
| New | +$318K | ﹤0.01% | 1108 |
|
|
2021
Q2 | – | Sell |
-5,760
| Closed | -$640K | – | 1700 |
|
|
2021
Q1 | $640K | Buy |
+5,760
| New | +$640K | 0.01% | 792 |
|
|
2020
Q4 | – | Sell |
-10,868
| Closed | -$949K | – | 1624 |
|
|
2020
Q3 | $949K | Sell |
10,868
-80,369
| -88% | -$7.02M | 0.02% | 665 |
|
|
2020
Q2 | $8.17M | Buy |
+91,237
| New | +$8.17M | 0.14% | 129 |
|
|
2020
Q1 | – | Sell |
-25,617
| Closed | -$2.94M | – | 1374 |
|
|
2019
Q4 | $2.94M | Buy |
25,617
+10,246
| +67% | +$1.18M | 0.04% | 344 |
|
|
2019
Q3 | $1.94M | Buy |
+15,371
| New | +$1.94M | 0.04% | 321 |
|
|
2019
Q2 | – | Sell |
-9,530
| Closed | -$833K | – | 1614 |
|
|
2019
Q1 | $833K | Buy |
+9,530
| New | +$833K | 0.02% | 570 |
|
|
2018
Q4 | – | Sell |
-13,803
| Closed | -$1.58M | – | 1158 |
|
|
2018
Q3 | $1.58M | Buy |
+13,803
| New | +$1.58M | 0.03% | 382 |
|
|
2017
Q4 | – | Sell |
-4,714
| Closed | -$211K | – | 1397 |
|
|
2017
Q3 | $211K | Buy |
+4,714
| New | +$211K | ﹤0.01% | 1374 |
|
|
2015
Q4 | – | Sell |
-9,493
| Closed | -$306K | – | 1436 |
|
|
2015
Q3 | $306K | Sell |
9,493
-9,725
| -51% | -$313K | 0.01% | 967 |
|
|
2015
Q2 | $795K | Buy |
+19,218
| New | +$795K | 0.02% | 683 |
|
|
2014
Q1 | – | Sell |
-25,611
| Closed | -$1.08M | – | 770 |
|
|
2013
Q4 | $1.08M | Buy |
+25,611
| New | +$1.08M | 0.05% | 356 |
|
|
2013
Q3 | – | Sell |
-5,613
| Closed | -$232K | – | 1018 |
|
|
2013
Q2 | $232K | Buy |
+5,613
| New | +$232K | 0.01% | 768 |
|